-
1صورة
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
2صورة
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
3صورة
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
4صورة
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
5
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
6
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients
-
7
المؤلفون: Andrea S. Fung (10047300), Karen Kopciuk (417770), Michelle L. Dean (2195977), Adrijana D’Silva (10047303), Shannon Otsuka (10047306), Alexander Klimowicz (3763963), Desiree Hao (6951728), Don Morris (141420), D. Gwyn Bebb (10047309)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Molecular Biology, Biotechnology, Developmental Biology, Cancer, Infectious Diseases, lung carcinogenesis, Methods Patient characteristics, CXCR 4 groups, multivariable analysis, study quantifies CXCR 4 expression, OS, HR, lung cancer evolution, Glans-Look Lung Cancer, cytokine receptor CXCR 4, stage non-small cell lung cancer pa., PH, Conclusions CXCR 4 expression increases, Tom Baker Cancer Centre, stage disease, cytokine receptors increases, resected stage I-III NSCLC patients, gender-specific recurrence-free, gender-specific differences, TMA, Hazard Ratio, stage IV patients